| miR-204-5p and miR-211-5p contribute to BRAF inhibitor resistance in melanoma M Díaz-Martínez, L Benito-Jardón, L Alonso, L Koetz-Ploch, E Hernando, ... Cancer research 78 (4), 1017-1030, 2018 | 149 | 2018 |
| The good and bad faces of the CXCR4 chemokine receptor J Teixido, M Martinez-Moreno, M Diaz-Martinez, S Sevilla-Movilla The International Journal of Biochemistry & Cell Biology 95, 121-131, 2018 | 83 | 2018 |
| Resistance to MAPK inhibitors in melanoma involves activation of the IGF1R–MEK5–Erk5 pathway L Benito-Jardón, M Díaz-Martínez, N Arellano-Sánchez, ... Cancer research 79 (9), 2244-2256, 2019 | 52 | 2019 |
| Plasma-derived extracellular vesicle analysis and deconvolution enable prediction and tracking of melanoma checkpoint blockade outcome A Shi, GG Kasumova, WA Michaud, J Cintolo-Gonzalez, M Díaz-Martínez, ... Science Advances 6 (46), eabb3461, 2020 | 45 | 2020 |
| Micro RNA‐125a promotes resistance to BRAF inhibitors through suppression of the intrinsic apoptotic pathway L Koetz‐Ploch, D Hanniford, I Dolgalev, E Sokolova, J Zhong, ... Pigment cell & melanoma research 30 (3), 328-338, 2017 | 41 | 2017 |
| A Blk–p190RhoGAP signaling module downstream of activated Gα13 functionally opposes CXCL12-stimulated RhoA activation and cell invasion RA Bartolome, M Diaz-Martinez, GP Colo, N Arellano-Sánchez, ... Cellular Signalling 26 (11), 2551-2561, 2014 | 12 | 2014 |
| New insights in melanoma resistance to BRAF inhibitors: a role for microRNAs M Díaz-Martínez, L Benito-Jardón, J Teixidó Oncotarget 9 (83), 35374, 2018 | 11 | 2018 |
| Facultad de Derecho CJ MARTÍNEZ Universidade Complutense de Madrid, 2017 | 2 | 2017 |
| Reply to: Biological role of miR-204 and miR-211 in melanoma (published in Oncoscience, Vol 5 (7-8), July 2018) M Díaz-Martínez, L Benito-Jardón, L Alonso, J Teixidó Oncoscience 5 (9-10), 262, 2018 | | 2018 |
